Description

Despite increasing interest in the use of human enhancement drugs (HEDs), our understanding of this phenomenon and the regulatory framework used to address it has lagged behind. Encompassing public health, epidemiology, neuroethics, sport science, criminology, and sociology, this book brings together a broad spectrum of scholarly insights and research expertise from leading authorities to examine key international issues in the field of HEDs. As "traditional" and other "new" drug markets have occupied much of the academic attention, there has been a lack of scholarly focus on human enhancement drugs. This book provides readers with a much-needed understanding of the illicit drug market of HEDs. The authors, from a variety of cultural contexts, disciplines and perspectives, include both academics and practitioners. Topics explored in this collection amongst others include:

• The anti-doping industry and performance and image enhancing drugs

• Steroids and gender

• The use of cognitive enhancing drugs in academia

• The use of sunless synthetic tanning products

• The (online) trade of HEDs

• Regulations of the enhancement drugs market

This collection will serve as a reference for students, academics, practitioners, law enforcement and others working in this area to reflect on the current state of research and consider future priorities. This detailed exploration will provide a valuable knowledge base for those interested in human enhancement drugs, while also promoting critical discussion.

Table of Contents

1. An introduction to human enhancement drugs

Katinka van de Ven, Kyle J.D. Mulrooney and Jim McVeigh

Part I: Understanding the use of human enhancement drugs in society

2. More than unnatural masculinity: gendered and queer perspectives on human enhancement drugs

Kathryn (Kate) Henne and Bridget Livingstone

3. The anti-doping industry coming of age: in search of new markets

Bengt Kayser and Verner Møller

4. The social construction of human enhancement: Implications for sports

Jay Coakley

5. Steroid Madness - Has the dark side of anabolic-androgenic steroids (AAS) been over-stated?

14. A preliminary attempt to scope the market for doping products in Italy

Letizia Paoli and Alessandro Donati

15. Trust, risk and deceit in the illicit medicines market: An analysis of the on- and offline trust relations between sellers and buyers of illicit medicines

Rosa Koenraadt

16. The open bar has closed: Changes in the patterns of doping supply in elite cycling

Bertrand Fincoeur

17. The supply of image and performance enhancing drugs (IPED) to local non-elite users in England: Resilient traditional and newly emergent methods

Ross Coomber and Mike Salinas

Part IV: Responding to human enhancement drugs

18. Different users, different interventions – On the ideal typology of anabolic androgenic steroid use and its implications for prevention and harm reduction

Anders Schmidt Vinther and Ask Vest Christiansen

19. The war on anabolic-androgenic steroids: an examination of U.S. legislative and enforcement efforts

Rick Collins

20. Doping in recreational sport: In pursuit of prevention before understanding

Geoff Bates and Susan Backhouse

21. How to respond to the increasing use of cognitive enhancers in academia?

Jason Mazanov

22. One size does not fit all: Tackling the issue of weight loss drug use

Jennifer Germain, Charlotte McLean and Conan Leavey

About the Editors

Dr Katinka van de Ven is a Research Fellow as part of the Drug Policy Modelling Program (DPMP) at the Social Policy Research Centre (SPRC), University of New South Wales. Katinka’s research focusses on the use and supply of performance and image enhancing drugs (PIEDs), which includes projects surrounding the prevention of PIED use, harm reduction policies and improving healthcare services for users. She is a Honorary Research Fellow at the Public Health Institute, Liverpool John Moores University. Katinka is Editor-in-Chief of Performance Enhancement & Health and the Director of the Human Enhancement Drug Network (HEDN) (www.humanenhancementdrugs.com).

Dr Kyle Mulrooney is a lecturer in Criminology at the University of New England the co-director of the Centre for Rural Criminology (UNE). His primary field of research is the Sociology of punishment in which he has examined issues ranging from the nexus between penal populism and political culture to the areas of drug policy and rural crime. He is also particularly interested in the use, supply, and regulation of enhancement drugs. Kyle holds a Ph.D. in Cultural and Global Criminology from the University of Kent and Universität Hamburg, an MA in the Sociology of Law from the International Institute for the Sociology of Law and a BA (Honours) in Criminology and Justice from the University of Ontario Institute of Technology.

Dr Jim McVeigh is the Director of the Public Health Institute at Liverpool John Moores University. He has worked within health/public health for over 30 years and has built an international reputation within the field of human enhancement drug use, in particular, the use of anabolic steroids and associated drugs within the general population.